Drug Discovery Services for Pharma & Biotech Professionals

Q: Can you handle infectious agents?

<div id="accordion-0179c80e9a-item-267d82b9e0" class="cmp-accordion__item" data-cmp-hook-accordion="item" data-cmp-data-layer="{"accordion-0179c80e9a-item-267d82b9e0":{"@type":"labcorpglobalaem/components/accordion/v1/accordion/item","repo:modifyDate":"2025-07-01T19:55:37Z","dc:title":"Why are PK studies important in drug development? "}}" data-cmp-expanded=""> Yes, we have BSL-2 space at our facilities in Ann Arbor, MI, and Denver, PA, and can work with a wide range of infectious agents. Learn more about our infectious disease and vaccine capabilities.

Q: Can you add pharmacokinetic (PK) and safety endpoints to efficacy studies?

<div id="accordion-0179c80e9a-item-267d82b9e0" class="cmp-accordion__item" data-cmp-hook-accordion="item" data-cmp-data-layer="{"accordion-0179c80e9a-item-267d82b9e0":{"@type":"labcorpglobalaem/components/accordion/v1/accordion/item","repo:modifyDate":"2025-07-01T19:55:37Z","dc:title":"Why are PK studies important in drug development? "}}" data-cmp-expanded=""> Yes, our discovery and safety teams work closely to efficiently run a study with efficacy, safety and PK, all under one roof. Explore our drug metabolism and pharmacokinetics (DMPK) solutions.

Q: Can you dose my respiratory drug by the inhaled route?

<div id="accordion-0179c80e9a-item-267d82b9e0" class="cmp-accordion__item" data-cmp-hook-accordion="item" data-cmp-data-layer="{"accordion-0179c80e9a-item-267d82b9e0":{"@type":"labcorpglobalaem/components/accordion/v1/accordion/item","repo:modifyDate":"2025-07-01T19:55:37Z","dc:title":"Why are PK studies important in drug development? "}}" data-cmp-expanded=""> Yes, we have an inhalation delivery team at our Huntingdon site that can administer drug by the inhalation route for evaluation of efficacy, PK and safety.

Q: We don’t have the resources to do DMPK screening in-house; how can we do it?

<div id="accordion-0179c80e9a-item-267d82b9e0" class="cmp-accordion__item" data-cmp-hook-accordion="item" data-cmp-data-layer="{"accordion-0179c80e9a-item-267d82b9e0":{"@type":"labcorpglobalaem/components/accordion/v1/accordion/item","repo:modifyDate":"2025-07-01T19:55:37Z","dc:title":"Why are PK studies important in drug development? "}}" data-cmp-expanded=""> Discovery DMPK screening can be done in a cost-effective manner. By leveraging technologies and resources, you can quickly and efficiently identify potential drug candidates with the desired pharmacokinetic properties. Learn about our in vitro screening capabilities.

Q: Can I do an early study that captures efficacy, PK and safety all in one?

<div id="accordion-0179c80e9a-item-267d82b9e0" class="cmp-accordion__item" data-cmp-hook-accordion="item" data-cmp-data-layer="{"accordion-0179c80e9a-item-267d82b9e0":{"@type":"labcorpglobalaem/components/accordion/v1/accordion/item","repo:modifyDate":"2025-07-01T19:55:37Z","dc:title":"Why are PK studies important in drug development? "}}" data-cmp-expanded=""> Yes. Because our discovery teams are closely associated with safety teams, we can readily run combined studies that capture all these endpoints, allowing you to be more efficient investigating your discovery compounds.

Q: My therapeutic target is expressed in cardiovascular tissue and I need to understand if it is a risk; can you help?

<div id="accordion-0179c80e9a-item-267d82b9e0" class="cmp-accordion__item" data-cmp-hook-accordion="item" data-cmp-data-layer="{"accordion-0179c80e9a-item-267d82b9e0":{"@type":"labcorpglobalaem/components/accordion/v1/accordion/item","repo:modifyDate":"2025-07-01T19:55:37Z","dc:title":"Why are PK studies important in drug development? "}}" data-cmp-expanded=""> Yes, we offer a wide range of non-GLP animal telemetry models to test your tool compound on blood pressure, ECG and cardiac function to help understand the cardiovascular risk. Explore cardiovascular safety assessments.

The discovery stage plays a pivotal role in shaping the success of a drug development program, impacting efficiency, cost and long-term outcomes. However, challenges such as high attrition rates, complex biological targets and the right candidate selection can create significant hurdles. Implementing a robust de-risking strategy means that only the most promising compounds advance, while partnering with a trusted laboratory optimizes resource allocation, accelerates development and enhances the likelihood of success.

Discover your top drug candidate and fast-forward to IND

Collaborating with Labcorp provides a strategic edge by enabling smarter decision-making, minimizing risks and accelerating progress. Our comprehensive discovery solutions support rapid study initiation, timely data delivery and expert scientific guidance to drive informed decisions and improve success rates. Whether you're developing small molecules, biologics or advanced therapies, we help advance your top candidates from hit validation to selection and beyond.

Extend your team’s expertise with scientific collaboration and insights
Improve probability of success with trusted data and insightful data interpretation delivered rapidly
Accelerate your program at scale with our global capabilities delivered with urgency

Drug discovery capabilities

Understand the efficacy of your molecule and the metabolic and pharmacokinetic profile of your compound while anticipating and responding to discovery challenges earlier.

Pharmacology
DMPK
Safety Toxicology

Key therapeutic expertise

Our scientific leaders provide valuable insights based on decades of expertise and are dedicated to delivering high-quality data to meet your timelines.

Oncology
Respiratory Diseases
Infectious Disease

Modality specialties

Reduce the time and risk in all stages of development, create custom-made antibody reagents and access a comprehensive suite of discovery vaccine testing services.

Cell & Gene Therapy
Antibodies
Vaccines

Discovery Studies: The Foundation of Drug Development Success

Download our free e-book a comprehensive guide packed with actionable de-risking strategies and expert advice to help you gain efficiency, reduce cost and find success in subsequent stages of development.

Dowload our free ebook - a comprehensive guide

Asset acquisition and exit

When your business goal is to exit, invest or partner, you can kick-start strategic conversations with the help of MarketPlace.

Expand your network by accessing our innovative platform that connects asset providers with asset seekers
Reach partnering goals faster by accelerating strategic conversations
Maximize the value of your partnering efforts; real connections are made every month

Discover MarketPlace

BLOG

Unlock the 3 keys to drug discovery success

Learn how to fast-track development of your discovery phase therapeutic to the next inflection point in a cost-efficient manner, derisk it and demonstrate the value needed to attract future investment.

Read the blog

NOW AVAILABLE

Patient-derived xenograft models

Improve your therapeutic efficacy predictions with our fully characterized patient-derived xenografts (PDX) representing multiple histotypes.

Unlock new possibilities with PDX

BROCHURE

Vaccine development testing

Leverage our scientific capabilities and experience for your next vaccine development project to save time and money.

Download the brochure

Frequently asked questions

Can you handle infectious agents?

Can you add pharmacokinetic (PK) and safety endpoints to efficacy studies?

Can you dose my respiratory drug by the inhaled route?

We don’t have the resources to do DMPK screening in-house; how can we do it?

Can I do an early study that captures efficacy, PK and safety all in one?

My therapeutic target is expressed in cardiovascular tissue and I need to understand if it is a risk; can you help?

Explore nonclinical solutions for each stage of your drug development journey

Discovery

Preclinical IND/CTA

Late-stage nonclinical

Ready to Discover the One?

Contact a representative

Managing Your Health

Diseases & Therapeutic Areas

Treatment Modalities & Methods

Scientific Lab Disciplines

Labs

Industries